@CDProteomics

Creative Proteomics has gradually developed into an integrated company that provides proteomics, metabolomics, glycomics, and bioinformatics services.

Shirley, NY
Joined September 2014
Sequencing shows who's in the gut. Metabolomics shows what they're doing. SCFAs, bile acids, indoles, TMAO — untargeted discovery + targeted absolute quantification. metabolomics.creative-proteo… #Metabolomics
1
1
14
Mitochondrial dysfunction is rarely a single-protein problem. End-to-end organelle proteomics: enrichment, LC-MS/MS quantification, PTM localization. creative-proteomics.com/subc… #MitochondrialProteomics
1
3
46
FASN proteolytic activation marks stress recovery in a 2024 Nature Metabolism study. The authors used untargeted metabolomics (LC-MS) from Creative Proteomics: doi.org/10.1038/s42255-023-0…
2
44
Direct HLA peptidomics captures the peptides cells actually present on HLA-I/II — including PTMs and cryptic epitopes prediction tools miss. Creative Proteomics: creative-proteomics.com/pept… #HLA
1
1
36
AI is shifting proteomics from protein ID toward virtual-cell modeling. A new Nature Methods Perspective maps six areas of impact and the infrastructure still needed for reproducibility. doi.org/10.1038/s41592-026-0… #Proteomics #AI #MassSpectrometry
1
47
Espino-Vázquez et al. mapped SPB/septal protein interactors in Neurospora crassa. For nano LC-MS/MS protein identification, the authors used Creative Proteomics. Published in Data in Brief (CC BY). DOI: 10.1016/j.dib.2023.109980 #Proteomics #CreativeProteomics
250
No database? De novo protein sequencing builds the sequence from MS/MS spectra. Creative Proteomics uses 6 proteases + HCD/ETD w-ion evidence to resolve Leu/Ile. creative-proteomics.com/prot… #Proteomics #CreativeProteomics
1
2
67
Top-down MS analyzes intact proteins, preserving co-occurring PTMs, terminal truncations, and sequence variants. Creative Proteomics covers 5 kDa to >150 kDa with Orbitrap/FT-ICR accuracy. creative-proteomics.com/prot… #Proteomics #MassSpectrometry #CreativeProteomics
1
1
44
Most cancer immunotherapy targets are MHC-bound peptides — invisible to standard proteomics. Immunopeptidome profiling reveals actual neoantigen presentation. creative-proteomics.com/ngpr… #Immunopeptidomics #Neoantigen
1
1
38
DDA misses 20-30% of the proteome per run. 4D-DIA adds ion mobility — every peptide fragmented, no missing values. creative-proteomics.com/ngpr… #DIA #Proteomics
1
1
48